Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.

Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth D; American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research.

Stroke. 2011 Jan;42(1):227-76. doi: 10.1161/STR.0b013e3181f7d043. Epub 2010 Oct 21.

2.

Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.

Pickett CA, Villines TC, Ferguson MA, Hulten EA.

Tex Heart Inst J. 2014 Aug 1;41(4):357-67. doi: 10.14503/THIJ-13-3879. eCollection 2014 Aug. Review.

3.

Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale.

Patti G, Pelliccia F, Gaudio C, Greco C.

Am J Cardiol. 2015 Mar 15;115(6):837-43. doi: 10.1016/j.amjcard.2014.12.051. Epub 2015 Jan 6. Review.

PMID:
25620037
4.

Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.

Kaplan ED, Sacco RL.

Curr Neurol Neurosci Rep. 2002 Jan;2(1):31-7. Review.

PMID:
11898580
5.

Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.

Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A.

Eur Heart J. 2013 Nov;34(43):3342-52. doi: 10.1093/eurheartj/eht285. Epub 2013 Jul 11. Review.

PMID:
23847132
6.

[Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].

Calvet D, Bracard S, Mas JL; French Society of Intensive Care.

Rev Neurol (Paris). 2012 Jun;168(6-7):512-21. doi: 10.1016/j.neurol.2012.01.587. Epub 2012 May 28. Review. French.

PMID:
22647807
7.

The role of warfarin and aspirin in secondary prevention of stroke.

Elkind MS.

Curr Cardiol Rep. 2004 Mar;6(2):135-42. Review.

PMID:
14759359
8.

Combination antiplatelet agents for secondary prevention of ischemic stroke.

Vande Griend JP, Saseen JJ.

Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Review.

PMID:
18823219
9.

Stroke subtypes and interventional studies for transient ischemic attack.

Lavallée P, Amarenco P.

Front Neurol Neurosci. 2014;33:135-46. doi: 10.1159/000351914. Epub 2013 Oct 11. Review.

PMID:
24157562
10.
11.

Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale.

Spencer FA, Lopes LC, Kennedy SA, Guyatt G.

BMJ Open. 2014 Mar 7;4(3):e004282. doi: 10.1136/bmjopen-2013-004282. Review.

12.

Patent foramen ovale and cryptogenic stroke: a complex neuro-cardio-vascular problem.

Spies C, Wong M.

Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1455-67. doi: 10.1586/erc.09.114. Review.

PMID:
19900028
13.

Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.

Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA.

JACC Cardiovasc Interv. 2013 Dec;6(12):1316-23. doi: 10.1016/j.jcin.2013.08.001. Epub 2013 Oct 16. Review.

14.

Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis.

Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD.

Neurology. 2009 Jul 14;73(2):89-97. doi: 10.1212/WNL.0b013e3181aa2a19. Epub 2009 May 13. Review.

PMID:
19439720
15.

Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis.

Meier B, Frank B, Wahl A, Diener HC.

Eur Heart J. 2012 Mar;33(6):705-13, 713a, 713b. doi: 10.1093/eurheartj/ehr443. Review.

16.

Anticoagulation and platelet antiaggregation therapy in stroke prevention.

Chong JY, Mohr JP.

Curr Opin Neurol. 2005 Feb;18(1):53-7. Review.

PMID:
15655403
17.

A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.

Pineda AM, Nascimento FO, Yang SC, Kirtane AJ, Sommer RJ, Beohar N.

Catheter Cardiovasc Interv. 2013 Nov 15;82(6):968-75. doi: 10.1002/ccd.25122. Epub 2013 Aug 5. Review.

PMID:
23832613
18.

New aspects of paradoxical embolism.

Lehmeyer S, Lindhoff-Last E.

Vasa. 2011 Jan;40(1):31-40. doi: 10.1024/0301-1526/a000067. Review.

PMID:
21283971
19.

Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.

Weber R, Weimar C, Diener HC.

Expert Opin Pharmacother. 2009 Aug;10(12):1883-94. doi: 10.1517/14656560903048934. Review.

PMID:
19558342
20.

Supplemental Content

Support Center